Language:

Results 1 - 20 of 23 for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method

Results 1 2

Refined by: Database: Springer Nature OA/Free Journals

Database: Wiley-Blackwell Open Access Titles

language: Chinese

Result Number	Material Type	Record Details and Options
1	Material Type: Article	A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study Cancer communications (London, England), 2019-11, Vol.39 (1), p.80-80, Article 80 [Peer Reviewed Journal] 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0426-0 ;PMID: 31775884 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
2	Material Type: Article	Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis Cancer communications (London, England), 2019-12, Vol.39 (1), p.81-81, Article 81 [Peer Reviewed Journal] 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0424-2 ;PMID: 31796105 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
3	Material Type: Article	The diagnostic and prognostic values of plasma Epstein‐Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study Cancer communications (London, England), 2019-03, Vol.39 (1), p.1-13 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0357-9 ;PMID: 30925939 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
4	Material Type: Article	Clinical outcomes of angiosarcoma: a single institution experience Cancer communications (London, England), 2019-08, Vol.39 (1), p.1-4 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0389-1 ;PMID: 31387642 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
5	Material Type: Article	The efficacy and safety of modified FOLFIRINOX as first‐line chemotherapy for Chinese patients with metastatic pancreatic cancer Cancer communications (London, England), 2019-05, Vol.39 (1), p.1-8 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0367-7 ;PMID: 31068222 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
6	Material Type: Article	An improved ileal conduit surgery for bladder cancer with fewer complications Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-10 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0366-8 ;PMID: 30999948 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
7	Material Type: Article	Target delineation and dose prescription of adaptive replanning intensity‐modulated radiotherapy for nasopharyngeal carcinoma Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-4 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0364-x ;PMID: 30987678 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
8	Material Type: Article	China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non‐small cell lung cancer after two lines of chemotherapy Cancer communications (London, England), 2019-06, Vol.39 (1), p.1-10 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0383-7 ;PMID: 31221221 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
9	Material Type: Article	The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first‐line chemotherapy of HER2‐negative metastatic breast cancer Cancer communications (London, England), 2019-01, Vol.39 (1), p.1-10 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-018-0346-4 ;PMID: 30606259 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
10	Material Type: Article	Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single‐center experience Cancer communications (London, England), 2019-09, Vol.39 (1), p.1-6 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0395-3 ;PMID: 31558165 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
11	Material Type: Article	Skull bone tumor: a review of clinicopathological and neuroimaging characteristics of 426 cases at a single center Cancer communications (London, England), 2019-03, Vol.39 (1), p.1-5 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0353-0 ;PMID: 30850028 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
12	Material Type: Article	Is cancer‐related death associated with circadian rhythm? Cancer communications (London, England), 2019-05, Vol.39 (1), p.1-5 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0373-9 ;PMID: 31088540 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
13	Material Type: Article	Primary intrathoracic liposarcoma: a clinical analysis of 31 cases Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-3 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0358-8 ;PMID: 30940199 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
14	Material Type: Article	Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast‐conserving therapy? Cancer communications (London, England), 2019-05, Vol.39 (1), p.1-12 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0371-y ;PMID: 31068224 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
15	Material Type: Article	Expression and clinical value of programmed cell death-ligand 1 (PD-L1)in diffuse large B cell lymphoma: a retrospective study Ai zheng, 2017-12, Vol.36 (12), p.767-777, Article 94 [Peer Reviewed Journal] 2017 The Author(s) ;COPYRIGHT 2017 John Wiley & Sons, Inc. ;2017. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © Wanfang Data Co. Ltd. All Rights Reserved. ;The Author(s) 2017 ;ISSN: 1000-467X ;ISSN: 2523-3548 ;ISSN: 1944-446X ;EISSN: 1944-446X ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-017-0262-z ;PMID: 29246182 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
16	Material Type: Article	A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy Cancer communications (London, England), 2019-10, Vol.39 (1), p.1-11 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0404-6 ;PMID: 31601270 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
17	Material Type: Article	Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China Cancer communications (London, England), 2019-07, Vol.39 (1), p.1-12 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0388-2 ;PMID: 31307542 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
18	$Molecular analysis of cell‐free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer$ $Molecular analysis of cell‐free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer$ Material Type: Article	Molecular analysis of cell‐free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-5 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0363-y ;PMID: 30999954 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
19	Material Type: Article	Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study Cancer communications (London, England), 2019-10, Vol.39 (1), p.1-4 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0405-5 ;PMID: 31601263 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
20	Material Type: Article	Irinotecan plus S‐1 versus S‐1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open‐labeled phase 3 trial Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-10 [Peer Reviewed Journal] The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0359-7 ;PMID: 30940189 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by